Roman Tremmel
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(DE)University of Tübingen(DE)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Childhood Cancer Survivors' Quality of Life, Radiation Therapy and Dosimetry, Genomics and Rare Diseases, Testicular diseases and treatments
Most-Cited Works
- → A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study(2023)470 cited
- → Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study(2016)331 cited
- → The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets(2021)242 cited
- → Genetic variation in human drug-related genes(2017)145 cited
- → Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes(2013)95 cited
- → A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort(2019)54 cited
- → Challenges and opportunities associated with rare-variant pharmacogenomics(2022)48 cited
- → Polymorphic Variation in TPMT Is the Principal Determinant of TPMT Phenotype: A Meta‐Analysis of Three Genome‐Wide Association Studies(2016)45 cited
- → Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels(2017)38 cited
- → HTCA: a database with an in-depth characterization of the single-cell human transcriptome(2022)35 cited